Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: D6OMY2L0WA

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD20 binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Large B-Cell, Diffuse 3 D016403 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650393
FDA SRS D6OMY2L0WA